L-R: Rodney Parsons-Parkin's Disease patient, Dr. Craig van Horne-UK assistant professor of neurosurgery and principle investigator of the clinical trial, Dr. Greg Gerhardt-UK professor of anatomy & neurobiology and director of the Morris K. Udall Parkinson's Disease Research Center of Excellence, Eli Capilouto- UK president, during a morning news conference concerning the University of Kentucky's trial of a promising new treatment strategy for Parkinson's Disease, held in the Charles Wethington Building on the UK campus in Lexington, Ky., Monday, November, 18, 2013. UK is the first in the U.S. to conduct a clinical trial to investigate the new treatment strategy. Photo by Charles Bertram | Staff
L-R: Rodney Parsons-Parkin's Disease patient, Dr. Craig van Horne-UK assistant professor of neurosurgery and principle investigator of the clinical trial, Dr. Greg Gerhardt-UK professor of anatomy & neurobiology and director of the Morris K. Udall Parkinson's Disease Research Center of Excellence, Eli Capilouto- UK president, during a morning news conference concerning the University of Kentucky's trial of a promising new treatment strategy for Parkinson's Disease, held in the Charles Wethington Building on the UK campus in Lexington, Ky., Monday, November, 18, 2013. UK is the first in the U.S. to conduct a clinical trial to investigate the new treatment strategy. Photo by Charles Bertram | Staff Herald-Leader
L-R: Rodney Parsons-Parkin's Disease patient, Dr. Craig van Horne-UK assistant professor of neurosurgery and principle investigator of the clinical trial, Dr. Greg Gerhardt-UK professor of anatomy & neurobiology and director of the Morris K. Udall Parkinson's Disease Research Center of Excellence, Eli Capilouto- UK president, during a morning news conference concerning the University of Kentucky's trial of a promising new treatment strategy for Parkinson's Disease, held in the Charles Wethington Building on the UK campus in Lexington, Ky., Monday, November, 18, 2013. UK is the first in the U.S. to conduct a clinical trial to investigate the new treatment strategy. Photo by Charles Bertram | Staff Herald-Leader

Video for mobile: Parkinson's patient praises UK treatment

November 18, 2013 03:52 PM

UPDATED November 19, 2013 06:52 AM

More Videos

  • Majority of football players had CTE shows study of donated brains

    A recent study looked at the donated brains of former football players including professional, semi-professional, collegiate, and high school athletes. Researchers found a change in the brains of former NFL players, known as chronic traumatic encephalopathy or CTE. CTE is a progressive degenerative disease of the brain. Researchers found that of the 202 brains studied, nearly 88 percent of them had CTE. The results were more pronounced among former NFL players.